Financials
- Market Capitalization 1.94 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-9.39
주가매출액비율
—
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2002 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 23.40 USD | -0.26% | +0.26% | +29.71% | +107.08% | 1.98 B USD | ||
| 2004 | VRDN Viridian Therapeutics, Inc. - Common Stock | 19.21 USD | +0.68% | -1.54% | +17.93% | -14.43% | 1.98 B USD | ||
| 2016 | NBTX Nanobiotix S.A. - ADSs | 40.52 USD | -2.69% | +5.82% | +14.46% | +668.88% | 1.96 B USD | ||
| 2025 | SION Sionna Therapeutics, Inc. - Common Stock | 43.47 USD | +2.07% | -1.11% | +20.72% | +10.50% | 1.96 B USD |